Arca Biopharma reported $-5680000 in EBIT for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US $ 2176M 324M
Arca Biopharma ABIO:US $ -5680000 1.58M
Biogen BIIB:US $ 940.9M 409.4M
Brainstorm Cell Therapeutics BCLI:US $ -7591000 2.12M
Bristol Myers Squibb BMY:US $ 3197M 9M
Cytokinetics CYTK:US $ -10874000 66.98M
Cytrx CYTR:US -1294610 692.11K
Daiichi Sankyo 4568:JP 34.38B 85.13B
Gilead Sciences GILD:US $ 2029M 868M
GlaxoSmithKline GSK:LN 1.82B 600M
Laboratory Of America LH:US $ 592.3M 109.4M
Myriad Genetics MYGN:US $ -17800000 2.9M
Otsuka Holdings 4578:JP 46.55B 4.31B
Pfizer PFE:US $ 12099M 2104M
United Therapeutics UTHR:US $ 201.8M 86.2M